Literature DB >> 2532496

Disability from dracunculiasis: effect on mobility.

G S Smith1, D Blum, S R Huttly, N Okeke, B R Kirkwood, R G Feachem.   

Abstract

A study was conducted in northeastern Imo State to define the disability and restriction of mobility associated with dracunculiasis. The study was part of an evaluation of the UNICEF-assisted Drinking Water Supply and Sanitation Project in Imo State, Nigeria. A sample of household units (100 in year 1, 195 in year 2) was visited every two weeks to determine who was affected by dracunculiasis and to characterize the extent of related disability. The average duration of symptoms was 12.7 weeks (range 3-29 weeks). Fifty eight per cent of all episodes of disease resulted in severe disability (with the individual unable to leave the compound) lasting a mean of 4.2 weeks (range 2-12). The mean period of severe disability was significantly higher for those aged 50 years and over than for those less than 50 years old. In the area studied, the disease occurred during the peak yam and rice harvest time and the period of preparation for the planting season. This is the first study to document systematically and prospectively the marked restriction of normal activity in affected individuals and the long duration of the disability. These findings can assist in improving estimates of the costs associated with dracunculiasis and of potential economic benefits if the disease were eradicated.

Entities:  

Mesh:

Year:  1989        PMID: 2532496     DOI: 10.1080/00034983.1989.11812323

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  9 in total

1.  When is a disease eradicable? 100 years of lessons learned.

Authors:  B Aylward; K A Hennessey; N Zagaria; J M Olivé; S Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

Review 2.  Dracunculiasis (Guinea worm disease) and the eradication initiative.

Authors:  Sandy Cairncross; Ralph Muller; Nevio Zagaria
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

Review 3.  Dracunculiasis (guinea worm disease).

Authors:  Chris Greenaway
Journal:  CMAJ       Date:  2004-02-17       Impact factor: 8.262

4.  [Social and economic impact of dracunculosis: a longitudinal study carried out in 2 villages in Benin].

Authors:  J P Chippaux; A Banzou; K Agbede
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

5.  Guinea worm infection in northern Nigeria: reflections on a disease approaching eradication.

Authors:  Brian Greenwood; Alice Greenwood; Andrew Bradley
Journal:  Trop Med Int Health       Date:  2017-04-05       Impact factor: 2.622

6.  Slaying little dragons: the impact of the Guinea Worm Eradication Program on dracunculiasis disability averted from 1990 to 2016.

Authors:  Elizabeth A Cromwell; Sharon Roy; Dieudonne P Sankara; Adam Weiss; Jeffrey Stanaway; Ellen Goldberg; David M Pigott; Heidi Larson; Stein Emil Vollset; Kristopher Krohn; Kyle Foreman; Peter Hotez; Zulfiqar Bhutta; Bayu Begashaw Bekele; Dumessa Edessa; Nicholas Kassembaum; Ali Mokdad; Christopher J L Murray; Simon I Hay
Journal:  Gates Open Res       Date:  2018-06-18

Review 7.  Contributions of the Guinea worm disease eradication campaign toward achievement of the Millennium Development Goals.

Authors:  Kelly Callahan; Birgit Bolton; Donald R Hopkins; Ernesto Ruiz-Tiben; P Craig Withers; Kathryn Meagley
Journal:  PLoS Negl Trop Dis       Date:  2013-05-30

Review 8.  The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination.

Authors:  Kebede Deribe; Kadu Meribo; Teshome Gebre; Asrat Hailu; Ahmed Ali; Abraham Aseffa; Gail Davey
Journal:  Parasit Vectors       Date:  2012-10-24       Impact factor: 3.876

9.  What It Means to Be Guinea Worm Free: An Insider's Account from Ghana's Northern Region.

Authors:  Adam J Weiss; Torben Vestergaard Frandsen; Ernesto Ruiz-Tiben; Donald R Hopkins; Franklin Aseidu-Bekoe; David Agyemang
Journal:  Am J Trop Med Hyg       Date:  2018-03-15       Impact factor: 2.345

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.